Acute invasive fungal sinusitis caused by mucormycosis at Buddhasothorn Hospital

Authors

  • Pattamavadee Chaichumporn Department of Otolaryngology, Buddhasothorn Hospital, Chachoengsao Mueang Chachoengsao District, Chachoengsao, Thailand

Keywords:

Mucormycosis, Acute invasive fungal sinusitis, Immunocompromise host

Abstract

Introduction: Acute invasive fungal sinusitis (AIFS) as caused by mucormycosis, is a fulminant and life-threatening condition with a high mortality rate. The disease progresses rapidly to adjacent structures, including the orbits and central nervous system. Early clinical manifestations are often nonspecific, leading to delayed diagnosis and treatment, which results in a substantial increase in patient morbidity and mortality. No previous studies of this condition have been conducted at Buddhasothorn Hospital.

Objectives
: To describe the demographic characteristics, clinical presentations, underlying comorbidities, treatment modalities, clinical outcomes, length of hospital stay, and further complications of patients at Buddhasothorn Hospital diagnosed with AIFS, as caused by mucormycosis

Methods: Data from all cases diagnosed with AIFS due to mucormycosis between 2017 and 2025 at Buddhasothorn Hospital were retrospectively collected. Because of the rarity of the disease, only 6 eligible cases identified from the hospital database were included.

Results: All cases were male with a mean age of 55 (2.22) years. Diabetes mellitus was the most common underlying comorbidity, presented in 4 of the 6 cases (66.67%). Mucorales infections were isolated and identified in 83.33% of cases. The ethmoid and maxillary sinuses were the most frequently involved of the paranasal sinuses (83.33%). The median interval from symptom onset to initiation of treatment was 10.00 days (range, 6.25–12.25). Ocular symptoms were the most common complaint, occurring in 50% of patients. The most frequently involved extra-sinonasal site was the orbit. All patients received systemic amphotericin B in combination with the surgical debridement of the affected sinuses and adjacent structures. The median duration of antifungal therapy was 52.00 days (range, 41.25–107.00). One patient died (16.67%).
No disease recurrence was observed among survivors upon hospital discharge.

Conclusions: Most cases at Buddhasothorn Hospital of patients with AIFS as caused by mucormycosis had diabetes mellitus as an underlying comorbidity. The most common
initial presentation was ocular. The ethmoid and maxillary sinuses were the most frequently affected sites, often extending to the orbits. Despite standard management, including surgical debridement and systemic antifungal therapy, the mortality rate was 16.67%.

References

Ngaotepprutaram P, Tantilipikorn P, Wongtawornruang P, Amornphichetkul K, Tritrakarn S-o,Ngamskulrungroj P, Lumyongsatien J. Mortality rate and predictive factors for invasive fungal rhinosinusitis: Experience in Siriraj hospital. SMJ. 2018; 70: 36-43. (in Thai)

Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020; 58: 1–464.

Payne SJ, Mitzner R, Kunchala S, Roland L, McGinn JD. Acute invasive fungal rhinosinusitis: a 15-year experience with 41 patients. Otolaryngol Head Neck Surg. 2016; 154: 759-64.

Turner JH, Soudry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope. 2013; 123: 1112- 8.

Akhondi H, Woldemariam B, Rajasurya V. Fungal sinusitis [internet]. 2023 [accessed Dec 24, 2025]. Avalable from: https://www. ncbi.nlm.nih.gov/books/NBK551496/

Middlebrooks E, Frost C, De Jesus R, Massini T, Schmalfuss I, Mancuso A. Acute invasive fungal rhinosinusitis: a comprehensive update of CT findings and design of an effective diagnostic imaging model. AJNR Am J Neuroradiol. 2015; 36: 1529-35.

Deshazo RD, O’Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997; 123: 1181-8.

Luo YT, Zhu CR, He B, Yan AH, Wei HQ. Diagnostic and therapeutic strategies of acute invasive fungal rhinosinusitis. Asian J Surg. 2023; 46: 58-65.

Silveira ML, Anselmo-Lima WT, Faria FM, Queiroz DL, Nogueira RL, Leite MG, et al. Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients. BMC Infect Dis. 2019; 19: 310.

Valera FC, do Lago T, Tamashiro E, Yassuda CC, Silveira F, Anselmo-Lima WT. Prognosis of acute invasive fungal rhinosinusitis related to underlying disease. Int J Infect Dis. 2011; 15: e841-e4.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. NEJM. 2009; 360: 129-39.

Khanna M, Challa S, Kabeil AS, Inyang B, Gondal FJ, Abah GA, et al. Risk of mucormycosis in diabetes mellitus: a systematic review. Cureus. 2021; 13: e18827.

Feldmesser M. Role of neutrophils in invasive aspergillosis. Infect Immun. 2006; 74: 6514-6.

Abers MS, Ghebremichael MS, Timmons AK, Warren HS, Poznansky MC, Vyas JM, editors. A critical reappraisal of prolonged neutropenia as a risk factor for invasive pulmonary aspergillosis. Open Forum Infect Dis; 2016: 12; 3: ofw036.

Craig JR. Updates in management of acute invasive fungal rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2019; 27: 29-36.

Hirabayashi KE, Idowu OO, Kalin-Hajdu E, Oldenburg CE, Brodie FL, Kersten RC, Vagefi MR. Invasive fungal sinusitis: Risk factors for visual acuity outcomes and mortality. Ophthalmic Plast Reconstr Surg. 2019; 35: 535-42.

Bhalla D, Bhalla AS, Manchanda S. Can imaging suggest the aetiology in skull base osteomyelitis? A systematic literature review. Pol J Radiol. 2021; 86: 309-21.

Mishra NK, Kumar S, Singh M, Panda SP. Inevitable impact of steroids and mucormycosis–a review. Journal of Pharmaceutical Research International. 2021; 33: 2158-72.

Nam SH, Chung YS, Choi YJ, Lee JH, Kim JH. Treatment outcomes in acute invasive fungal rhinosinusitis extending to the extrasinonasal area. Sci Rep. 2020; 10: 3688.

Downloads

Published

31-08-2026

How to Cite

1.
Chaichumporn P. Acute invasive fungal sinusitis caused by mucormycosis at Buddhasothorn Hospital. Bu J Med [internet]. 2026 Aug. 31 [cited 2026 Sep. 4];13(2):47-59. available from: https://he01.tci-thaijo.org/index.php/BJmed/article/view/284930

Issue

Section

Case report